item1.txt
The Company has a 52-to-53-week fiscal year that ends on the last Saturday in June.
The Company early-adopted ASU 2017-12 in the first quarter of fiscal year 2018.
This standard provides guidance about the reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. ASU 2018-02 is effective for the Company in the first quarter of fiscal year 2019, with early adoption permitted, including adoption in any interim period for which financial statements have not yet been issued.
The Company's Level 3 assets and liabilities consist of contingent consideration liabilities related to an acquisition during the three months ended March 31, 2018.
During the nine months ended March 31, 2018 and the year ended June 24, 2017, there were no transfers in or out of Level 3 from other levels in the fair value hierarchy.
In the nine months ended March 31, 2018 and the year ended June 24, 2017, the Company did not recognize any impairment charges on short-term investments.
Amortized discount and expenses, as well as interest expense associated with the notes, were $12.4 million and $7.9 million during the three months ended March 31, 2018 and March 25, 2017, respectively.
Amortized discount and expenses, as well as interest expense associated with the notes, were $37.1 million and $26.3 million during the nine months ended March 31, 2018 and March 25, 2017, respectively.
The estimated fair value of the Company’s outstanding debt obligations was approximately $1,485 million as of March 31, 2018.
The Company recorded interest expense of $12.5 million and $8.1 million during the three months ended March 31, 2018, and March 25, 2017, respectively.
The Company recorded interest expense of $37.6 million and $26.8 million during the nine months ended March 31, 2018 and March 25, 2017, respectively.
RSUs granted to employees typically vest over a four-year period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period.
The expenses included in the Condensed Consolidated Statements of Income for RSUs include expenses related to MSUs of $2.2 million and $1.1 million for the three months ended March 31, 2018 and March 25, 2017, respectively and $5.8 million and $2.5 million for the nine months ended March 31, 2018 and March 25, 2017, respectively.
As of March 31, 2018, there was less than $0.1 million of total unrecognized stock compensation cost related to less than 0.1 million unvested stock options, which is expected to be recognized over a weighted average period of approximately 0.3 years.
The fair value of RSUs and other awards under the Company’s 1996 Plan is estimated using the value of the Company’s common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company’s common stock prior to vesting.
The weighted-average fair value of RSUs and other awards granted was $54.81 and $42.30 per share for the three months ended March 31, 2018 and March 25, 2017, respectively and $44.49 and $37.02 per share for the nine months ended March 31, 2018 and March 25, 2017, respectively.
The Company withheld shares totaling $9.6 million and $21.2 million in value as a result of employee withholding taxes based on the value of the RSUs on their vesting date for the three and nine months ended March 31, 2018.
As of March 31, 2018, there was $156.4 million of unrecognized compensation expense related to 6.1 million unvested RSUs and other awards, which is expected to be recognized over a weighted average period of approximately 2.8 years.
The weighted-average fair value of MSUs granted was $51.03 and $37.29 per share for the nine months ended March 31, 2018 and March 25, 2017, respectively.
In the three and nine months ended March 31, 2018, the Company recorded an income tax provision of $28.7 million and $328.0 million, respectively, compared to $30.2 million and $75.7 million for the three and nine months ended March 25, 2017, respectively.
The Company’s effective tax rate for the three and nine months ended March 31, 2018 was 12.9% and 54.6%, respectively, compared to 17.7% and 15.6% for the three and nine months ended March 25, 2017, respectively.
The Company’s effective tax rate for the three months ended March 31, 2018 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, and $4.6 million of discrete excess tax benefits generated by the settlement of share-based awards, partially offset by $5.1 million of discrete interest accruals for unrecognized tax benefits.
The Company’s effective tax rate for the nine months ended March 31, 2018 was higher than the statutory rate primarily due to a $236.9 million discrete provisional charge for the Repatriation Tax, a $13.7 million discrete charge to remeasure deferred taxes as of the enactment date of the Act, and $13.1 million of discrete interest accruals for unrecognized tax benefits, partially offset by earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates and $8.3 million of discrete excess tax benefits generated by the settlement of share-based awards.
The Company's aggregate product warranty liabilities as of March 31, 2018 and March 25, 2017 were $6.1 million and $5.3 million, respectively.
The company also agreed to pay up to an additional $16.0 million if the acquired business achieves certain financial milestones for the annual periods ending August 31, 2018 and August 31, 2019.
No indicators or instances of impairment were identified in the nine months and fiscal year ended March 31, 2018 and June 24, 2017, respectively.
The Company did not record any impairment of long-lived assets during the three months ended March 31, 2018.
During the nine months ended March 31, 2018, the Company recorded $0.9 million of impairment of long-lived assets in the Company's Condensed Consolidated Statements of Income.
The Company reached its conclusion regarding the asset impairment due to changes, during the nine months ended March 31, 2018, in the financial condition of certain investments in privately held companies which indicated an other than temporary impairment.
During the three and nine months ended March 25, 2017, the Company recorded $1.0 million and $7.5 million, respectively, in impairment of long-lived assets in the Company’s Condensed Consolidated Statements of Income.
The Company reached its conclusion regarding the asset impairment after the determination was made that due to factors during the nine months ended March 25, 2017, the financial condition of the privately held companies indicated an other than temporary impairment.
During the second quarter of fiscal year 2016, the Company classified the micro-electromechanical systems (MEMS) business line, including associated tangible assets and goodwill, as held for sale but no impairment charge was recorded as the carrying value of the product lines' associated assets approximated or was less than the fair value, less cost to sell.
During the first quarter of fiscal year 2017, the Company completed the sale of this business line for approximately $42.2 million, resulting in a gain of $26.6 million, included in Other operating income (expenses), net in the Condensed Consolidated Statements of Income.
During the three and nine months ended March 31, 2018, the Company recorded $2.3 million and $14.2 million, respectively, in “Severance and restructuring expenses” in the Condensed Consolidated Statements of Income related to various restructuring plans designed to reduce costs.
During the three and nine months ended March 25, 2017, the Company recorded $0.5 million and $11.3 million, respectively, in “Severance and restructuring expenses” in the Condensed Consolidated Statements of Income related to various restructuring plans designed to reduce costs.


item2.txt
Net revenues were $648.6 million and $581.2 million for the three months ended March 31, 2018 and March 25, 2017, respectively.
Net revenues were $1,846.9 million and $1,693.6 million for the nine months ended March 31, 2018 and March 25, 2017, respectively.
Research and development expenses were $114.4 million and $113.2 million for the three months ended March 31, 2018 and March 25, 2017, respectively, which represented 17.6% and 19.4% of net revenues for each respective period.
Research and development expenses were $338.9 million and $340.0 million for the nine months ended March 31, 2018 and March 25, 2017, respectively, which represented 18.3% and 20.1% of net revenues for each respective period.
Selling, general and administrative expenses were $81.3 million and $74.0 million for the three months ended March 31, 2018 and March 25, 2017, respectively, which represented 12.5% and 12.7% of net revenues for each respective period.
Selling, general and administrative expenses were $240.3 million and $216.4 million for the nine months ended March 31, 2018 and March 25, 2017, respectively, which represented 13.0% and 12.8% of net revenues for each respective period.
Severance and restructuring expenses were $2.3 million and $0.5 million for the three months ended March 31, 2018 and March 25, 2017, respectively, which represented 0.4% and 0.1% of net revenues for each respective period.
Severance and restructuring expenses were $14.2 million and $11.3 million for the nine months ended March 31, 2018 and March 25, 2017, respectively, which represented 0.8% and 0.7% of net revenues for each respective period.
Other operating expenses (income), net were $0.3 million and $1.7 million during the three months ended March 31, 2018 and March 25, 2017, respectively, which represented less than 0.1% and 0.3% of net revenues for each respective period.
This net decrease in other operating expense of $1.4 million was primarily driven by losses on the sale of fixed assets during the three months ended March 25, 2017.
In the three and nine months ended March 31, 2018, we recorded an income tax provision of $28.7 million and $328.0 million, respectively, compared to $30.2 million and $75.7 million for the three and nine months ended March 25, 2017, respectively.
Our effective tax rate for the nine months ended March 31, 2018 was higher than the statutory rate primarily due to a $236.9 million discrete provisional charge for the Repatriation Tax, a $13.7 million discrete charge to remeasure deferred taxes as of the enactment date of the Act, and $13.1 million of discrete interest accruals for unrecognized tax benefits, partially offset by earnings of foreign subsidiaries, generated primarily by our international operations managed in Ireland, that were taxed at lower rates, and $8.3 million of discrete excess tax benefits generated by the settlement of share-based awards.
Cash provided by operating activities was $672.8 million in the nine months ended March 31, 2018, an increase of $136.1 million compared with the nine months ended March 25, 2017.
Cash used in investing activities increased by $388.8 million for the nine months ended March 31, 2018 compared with the nine months ended March 25, 2017.
The increase was due primarily to a $722.0 million increase in purchases of available-for-sale-securities, partially offset by $397.5 million increase in proceeds from maturity of available-for-sale securities during the nine months ended March 31, 2018.
In the fiscal quarter ended March 31, 2018, the Company repurchased approximately 2.1 million shares of its common stock for approximately $127.7 million.


item4.txt
31.2Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act


part2.txt
31.1Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act


